Spotlight on CIDP: Evolving Perspectives on Disease and Treatment
The evolving treatment landscape in CIDP aims to address the unmet needs of residual disability and treatment burden to improve the quality of life for patients. Our symposium explored the heterogeneous clinical presentation, prognosis, underlying biology, and disease pathophysiology of CIDP, followed by an expert panel discussion that delved into emerging perspectives on CIDP disease and treatment.
Medical Symposium
Speaker Biographies
*This Symposium is intended for medical and scientific exchange purposes with health care professionals and patient advocacy group leadership only. This program is non-promotional, is sponsored by Sanofi Medical, and the content contained in this presentation was developed by Sanofi Medical in collaboration with the speakers. The speakers were compensated by Sanofi in connection with this presentation. This presentation is not eligible for CME. This Symposium discusses treatment agents that are investigational and no conclusions regarding safety and efficacy should be drawn. For approved agents referenced in this Symposium, please refer to the prescribing information available in your country.